TGFB1 and glioblastoma: Our results show that the brain-permeable pharmacological inhibitor of CTH, PAG, is not a cytotoxic drug but can attenuate significantly the GBM cell proliferation and the TGF-β-induced cell migration in mouse glioblastoma cells by an H2S-dependent mechanism.